• Cy5-TPP riboswitch:
5ʹCy5−CAG UAC UCG GGG UGC CCU UCU GCG UGA AGG CUG AGA AAU ACC CGU AUC ACC UGA UCU GGA UAA UGC CAG CGU AGG GAA GUG CUG-3ʹ
Calf thymus DNA was purchased from ThermoFisher Scientific at 10mg/mL.
All small molecules were purchased from ChemBridge Hit2Lead ® , then analyzed for purity via LC/MS, 1 H NMR, and 13 C NMR. Several compounds were purified using HPLC at 10-95% Acetonitrile gradient in 0.1% THF-MilliQWater, and analyzed again prior to dissolution in D-DMSO to a concentration of 20 mM. See Table below 
Small Molecule Microarray

S3
The small molecule microarray screening procedure was performed as previously published [1] Various compounds can be immobilized to the slides by covalently bonding either an amine or primary alcohol on each compound to the isocyanate. 7024 compounds purchased from Chembridge and diluted to 10mM DMSO stocks were printed in duplicate on the slides, then were exposed to pyridine vapor overnight in a vacuum desiccator. The compound-appended slides were then exposed to a 1:20 polyethylene glycol:DMF solution to quench unreacted surface.
The Alexofluor647-hras-1 Y i-motif was diluted to 150nM in 50mM KCl, 50mM TrisHCl, 0.05% Tween, pH 6.05 buffer and was annealed for 3 minutes at 90 C, followed by cooling to 23 C. The printed SMM slides were incubated at 23C with the A647-hras-1 Y for 2h. Slides were then washed three times with Tris buffer and then with milliQ water and dried by centrifugation for 2 min at 4000RPM. The fluorescence of the slides was measured on an Innopsys Innoscan 1100 AL Microarray Scanner (650 nm excitation, 670 nm emission). 61 hits out of the 7024 compounds were discovered to bind to the i-motif, and 31 of the hits were selective (0-2 oligonucleotides hit) for hras-1 Y (0.86% hit rate).
Synthesis of 2-((2-amino-6-(4-(1-(pyrrolidin-1-yl)ethyl)phenyl) pyrimidin-4-yl)amino)ethan-1-ol
suspended in a 2mL:1mL mixture of toluene to ethanol, and 0.5 mL of 2M Na 2 CO 3 was added. Upon stirring, the solution was activated by tetrakis(triphenylphosphine) palladium(0) (0.0459g, 0.0000397mmol), then (4-(1-(pyrrolidin-1-yl)ethyl)phenyl)boronic acid (0.0418g, 0.00019mmol) was added to the solution. The reaction was heated to reflux. At 1.5h and 4.5h, the reaction was cooled to 23 o C and excess tetrakis(triphenylphosphine)palladium(0) (0.00184g, 0.00159mmol) (Strem Chemicals) and (4-(1-(pyrrolidin-1-yl)ethyl)phenyl)boronic acid (0.0104g, 0.0475mmol) were added.
The reaction was heated to reflux overnight. The reaction was diluted with water and extracted with ethyl acetate (2x 20mL), then briefly washed with 0.2M of NaOH. The combined organic layers were dried with sodium sulfate. The product was purified by HPLC at a 10-95% acetonitrile gradient in 0.1%THF-MilliQ Water. 
Surface Plasmon Resonance (SPR)
A Biacore 3000 (Biacore, Inc.; GE Healthcare Lifesciences) instrument was used for all SPR experimentation. All experiments were performed at 23C. Gold plated Sensor
Chip CM5 (GE Healthcare Lifesciences) were primed twice with SPR buffer (50mM KCl, 50mM Tris-HCl, pH 6, 2.5% DMSO, 0.005% Tween) prior to injection of reagents. A 0.4M EDC/ 0.1M NHS solution flowed over the chip at 5L/min. Strepavidin (ThermoFisher) was then immobilized to the chip to ~24000 Reference Units (RU) for both flow cells. The streptavidin-laced surface was then blocked with 10mM ethanolamine pH8 solution. A 1M NaCl/50mM NaOH solution then flowed at 50L/min over the surface to remove any non-bound streptavidin. Biotin appended hras-1 Y oligos were purchased from Integrated DNA Technologies Inc (HPLC purified) and were annealed at 95C for 3 minutes, then were cooled to room temperature for 1h. A 10M oligo stock was injected at 2uL/min over the second flow cell. The flow cells were reference subtracted and had a 2000-3000 RU difference.
Each compound was diluted to either 300M or 100M, then diluted two-fold in the SPR buffer, and varied depending on each compound. Each dilution flowed over the flow cell at 30L/min and was repeated two times.
The SPR data were analyzed using BIAevaluation Software (GE Healthcare Lifesciences). Each trace was either fit to the Langmuir model, or was evaluated using methods for non-specific binding. If there was non-specific binding present, each trace peak was recorded and fit into Prism (Graphpad). Then, the curve was analyzed One
Site-Total to determine a K D . 
FRET of hras-1 Y and SNJ-91
Experiments were performed on a Photon Technology 400 Fluorimeter and detected into Felix GX 4.2.2 software. Fluorescence emission measurements were measured in a Quartz SUPRASIL ® cuvette (10x4 mm path length) purchased from Hellma ® Analytics (Germany). All measurements were excited at 488 nm and data was collected in an emission range of 500-650 nm, identical to Migletta et. al. [3] hras-1 Y was annealed at 90C and let cool for 1h. Then, 50nM was suspended into FRET buffer (50mM KCl, 50mM Tris-Acetate, pH 6 or pH8 buffer with 5% DMSO) totaling 1mL of sample. Each compound was diluted in the FRET buffer (without added DMSO, and with 50nM FREThras-1 Y ) to 1mM and was titrated into the sample at varying concentrations. After every titration, the sample was allowed to incubate at 23C for 10 minutes prior to excitation. 
Modeling Methods
Docking was done using the crystal structure of the d(ACCCT) i-motif (PDB code 1cn0). [4] The terminal adenine and thymine residues were deleted. The central core of the i-motif is not symmetrical, but adopts a liferaft-like curved structure ( Figure S58 ) with the phosphate groups on one side projecting outward to give a flat surface, and the phosphate groups on the other side projecting upwards to form a groove. The width of this groove is very close to the widened minor groove of B-DNA upon binding side-byside ligands such as distomycin or other lexitropsins [5, 6] but the groove itself is shallower. This seemed the most logical binding site for small molecules interacting with the i-motif core. [7, 8] An ensemble of structures for compounds 1 (Figure 7a and 7b) and 2 ( Figure S59 ) was generated in LigPrep [9] by enumerating ionization states over pH 6-8, stereoisomers, and low-energy unsaturated ring conformations. Structures were docked to the i-motif core with rDock, a docking program developed for nucleic acid targets as well as proteins. [10] Fifty docking runs were performed for each structure, using the standard docking protocol and the SF5 scoring function that includes a desolvation potential. 
